A team of urologists and pain specialists just crunched the numbers on more than 10,000 urology surgery patients and found a clear pattern: the dose of opioid painkillers patients got when they left the hospital had a huge impact on whether they came back asking for more pills. The sweet spot wasn’t too high and not too low. Patients who got exactly the right amount had the lowest refill rates. Patients who got nothing or way too much? They were the ones most likely to call their doctor a week later for another prescription. The study was presented at the American Urological Association (AUA) annual meeting in Washington, D.C., this week, and it’s forcing doctors to rethink how they send patients home after common procedures like prostate biopsies or kidney stone removals.

The researchers pulled data from the IBM Watson Health Marketscan database, which tracks insurance claims for millions of Americans. They zeroed in on patients who had one of five common urology procedures between 2018 and 2022. What jumped out was how dramatically the refill rates changed based on the number of opioid pills patients were prescribed at discharge. Patients who got 11 to 20 pills—the middle of the road—had the lowest refill rates. But patients who got no opioids at all were 2.5 times more likely to ask for a refill compared to the middle group. Even worse, patients who got more than 30 pills were nearly twice as likely to come back for another prescription. It’s a Goldilocks problem: too little pain relief, and patients suffer. Too much, and they either take it all or just keep calling for more.

Opioid refill rates spike when doses are extreme

The numbers don’t lie. Among the 10,234 patients in the study, 1,842—about 18%—ended up needing at least one opioid refill within 30 days of surgery. The refill rates broke down like this: patients discharged with no opioids had a 22% refill rate. Those given 1 to 10 pills had a 19% refill rate. The 11-to-20-pill group? Just 12%. But the group given 21 to 30 pills saw a jump back up to 17%. And the biggest spike? Patients sent home with more than 30 pills had a 20% refill rate, nearly double the sweet spot. The researchers controlled for age, sex, type of surgery, and even pre-existing pain conditions, and the pattern held. It wasn’t about who the patients were—it was about how many pills they got.

What’s driving this isn’t just pain. It’s the way opioids work in the body and the way prescriptions work in the system. Patients who feel undertreated are more likely to call their doctor for help. Patients who get a massive bottle of pills might take a few, then realize they don’t need the rest—but they’re left with a prescription they don’t want to throw away, and their doctor’s number in their phone just in case. Either way, it’s a recipe for refills.

Doctors are rethinking post-op pain scripts

This study is landing at a time when doctors are under intense pressure to cut opioid prescriptions after surgery. The CDC has been pushing for years to reduce opioid overuse, and hospitals are adopting stricter guidelines for how many pills to give after everything from gallbladder removal to C-sections. Urology isn’t exempt. Procedures like cystoscopy or ureteroscopy can leave patients in real pain for days, but the standard 30-pill bottle is starting to look like overkill—and under-treatment.

The lead author of the study, Dr. Brandon Van Asseldonk, a urologist at Mayo Clinic in Rochester, Minnesota, says the findings suggest doctors need to personalize opioid prescriptions instead of relying on one-size-fits-all scripts. “We’re seeing that the middle ground works best,” he told MedPage Today. “It’s not about cutting opioids completely. It’s about finding the right amount so patients don’t end up in a cycle of refills.” His team is now testing whether adding non-opioid painkillers like ibuprofen or acetaminophen to the mix can reduce refill rates even further.

The bigger picture: opioid refills fuel the crisis

The stakes here go beyond patient comfort. Every unnecessary opioid refill adds fuel to the fire of the opioid epidemic. Studies show that patients who get refills after surgery are more likely to become long-term opioid users, even if they started with just a few pills. The Sackler family—owners of Purdue Pharma, the maker of OxyContin—are in court right now for their role in pushing opioids. Meanwhile, hospitals are scrambling to balance pain management with safety. The AUA isn’t the only group pushing for change. The American College of Surgeons has been running campaigns for years to get surgeons to prescribe fewer opioids after common operations.

So what’s next? The researchers are calling for bigger studies to confirm their findings and figure out the best way to dose opioids after urology surgery. In the meantime, doctors are already adjusting their scripts. Some are switching to non-opioid painkillers entirely for milder procedures. Others are capping opioid prescriptions at 20 pills and making sure patients know how to taper off safely. The goal isn’t to leave patients in pain—it’s to stop the cycle of refills before it starts.

What You Need to Know

  • Source: MedPage Today
  • Published: May 17, 2026 at 18:15 UTC
  • Category: Health
  • Topics: #medicine · #health · #clinical · #too-much · #too-little-opioid · #pain-relief-may

Read the Full Story

This is a curated summary. For the complete article, original data, quotes and full analysis:

Read the full story on MedPage Today →

All reporting rights belong to the respective author(s) at MedPage Today. GlobalBR News summarizes publicly available content to help readers discover the most relevant global news.

Curated by GlobalBR News · May 17, 2026

🇧🇷 Resumo em Português

O erro na dosagem de opioides na alta hospitalar após cirurgias urológicas pode estar por trás do aumento nos índices de retorno de pacientes para novos analgésicos. Segundo um estudo recente, tanto a superdosagem quanto a subdosagem desses medicamentos dobram as chances de os pacientes necessitarem de receitas adicionais, levantando um alerta para os riscos da automedicação e do manejo inadequado da dor no pós-operatório.

A pesquisa, publicada em revista especializada, destaca um problema crítico no sistema de saúde brasileiro, onde a dor mal controlada ainda é tratada de forma superficial, apesar da crescente conscientização sobre os perigos dos opioides. No Brasil, onde cirurgias urológicas como prostatectomias e nefrectomias são comuns, a falta de protocolos claros para a prescrição de analgésicos no momento da alta pode agravar casos de dependência ou, ao contrário, deixar o paciente sem alívio adequado. Além disso, a cultura de automedicação e a facilidade em obter analgésicos sem prescrição — mesmo controlados — tornam o cenário ainda mais preocupante.

Diante desse quadro, especialistas brasileiros já começam a discutir a implementação de diretrizes mais rígidas para a prescrição de opioides, inspiradas em modelos internacionais, enquanto hospitais públicos e privados são pressionados a rever seus protocolos de alta.

🇪🇸 Resumen en Español

Un error en la dosis de opioides al alta tras una cirugía urológica multiplica las probabilidades de que el paciente necesite reingresos por alivio del dolor. Una investigación reciente ha revelado que tanto la administración excesiva como insuficiente de estos fármacos incrementa hasta en un 30% las solicitudes de recetas adicionales en los días siguientes a la operación.

El estudio subraya la urgencia de ajustar los protocolos de prescripción postoperatoria, ya que un manejo inadecuado no solo afecta a la recuperación del paciente, sino que también eleva los costes sanitarios y el riesgo de dependencia. Para la población hispanohablante, este hallazgo es especialmente relevante, pues en muchos países de habla hispana los opioides siguen siendo una opción recurrente en el tratamiento del dolor, a pesar de su potencial peligro. La evidencia apunta a que una dosificación más precisa y personalizada podría reducir complicaciones y mejorar la calidad de vida tras la intervención.